Stryker Corporation vs Xylem, Inc. — how do they compare? Stryker Corporation trades at $319.04 (market cap $122.35B), while Xylem, Inc. trades at $117.66 (market cap $28.67B). The key difference: Stryker Corporation is far larger — about 4.3× Xylem, Inc.'s market cap, and Xylem, Inc. pays the higher dividend (1.43%). Which is the better fit depends on your goals.
| SYK | XYL | |
|---|---|---|
Market Cap | $122.35B | $28.67B |
Sector | Technology | Industrials |
52-Week High | $403.53 | $152.95 |
52-Week Low | $282.58 | $106.34 |
Enterprise Value | $134.10B | $29.92B |
Dividend Yield | 1% | 1.43% |
Trailing returns across standard periods
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →